This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Long-acting risperidone most economical choice in schizophrenia. Inpharma Wkly. 1489, 4 (2005). https://doi.org/10.2165/00128413-200514890-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514890-00006